Research News
Dartmouth Health researchers part of the developing first nasal spray vaccine for COVID-19
DHMC is sole U.S. research site for this project
Dartmouth Health Children’s helps identify a more effective way to care for newborns exposed to opioids in the womb
A groundbreaking multi-centered clinical trial has demonstrated an effective way to safely care for infants with Neonatal Opioid Withdrawal Syndrome.
Dartmouth Health awarded $11.6M federal grant to address rural healthcare challenges
The grant will fund a new Center for Rural Health Care Delivery Science and support faculty to conduct research that will advance the understanding of healthcare delivery in a rural setting.
Where do Prouty donations go? Spring 2023
The newest Prouty Pilot cancer research projects underway at Dartmouth Cancer Center
Q&A with Linda T. Vahdat, MD, MBA: Advancing the patient experience through research
Patients don’t need to travel to Boston or New York for life-changing clinical trials. Linda T. Vahdat, MD, MBA, outlines how she's helping transform research and patient care as Deputy Director of Dartmouth Cancer Center.
Precision cancer medicine with whole exome sequencing
Sequencing a patient’s entire genetic code helps pin down the right treatments.
Study led by Dartmouth Health cardiologist finds significant reduction in dementia risk for AFib patients
Catheter ablation was associated with significantly lower risk of dementia compared to treatment with anti-arrhythmic drugs only
Innovation research with the Breast Cancer Locator
In this video, breast surgeon Richard J. Barth, Jr., MD, shows how and why the invention of the Breast Cancer Locator solves a common problem.
A new hub for cancer research
How science from a new institute at Dartmouth Cancer Center is already benefitting patients.
Joint study between DHMC Neurology, LoveYourBrain Foundation finds benefit in specialized yoga program for MS patients
The study showed that the program improved fatigue, positive affect, and anxiety among MS patients, and has potential to be a viable complementary, community-based therapy model for MS.